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Vibrio vulnificus biotype 2-serovar E is a zoonotic clonal complex that can cause death
by sepsis in humans and fish. Unlike other biotypes, Bt2 produces a unique type of
MARTXVv (Multifunctional-Autoprocessive-Repeats-in-Toxin; RtxA13), which is encoded
by a gene duplicated in the pVvBt2 plasmid and chromosome II. In this work, we
analyzed the activity of this toxin and its role in human sepsis by performing in vitro,
ex vivo, and in vivo assays. First, we demonstrated that the ACD domain, present
exclusively in this toxin variant, effectively has an actin-cross-linking activity. Second, we
determined that the whole toxin caused death of human endotheliocytes and monocytes
by lysis and apoptosis, respectively. Finally, we tested the hypothesis that RtxA13
contributes to human death caused by this zoonotic serovar by triggering an early
cytokine storm in blood. To this end, we used a Bt2-SerE strain (R99) together with
its rtxA13 deficient mutant, and a Bt1 strain (YJ016) producing RtxA11 (the most studied
MARTXVv) together with its rtxA11 deficient mutant, as controls. Our results showed
that RtxA13 was essential for virulence, as R9911rtxA13 was completely avirulent in
our murine model of infection, and that R99, but not strain YJ016, induced an early,
strong and dysregulated immune response involving the up-regulation of a high number
of genes. This dysregulated immune response was directly linked to RtxA13. Based on
these results and those obtained ex vivo (human blood), we propose a model of infection
for the zoonotic serovar of V. vulnificus, in which RtxA13 would act as a sepsis-inducing
toxin.
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INTRODUCTION
Vibrio vulnificus is an autochthonous inhabitant of marine and estuarine waters located in tropical,
subtropical, and temperate ecosystems (Oliver, 2015). Currently, the species is expanding to cooler
areas such as, the Baltic Sea coast due to global warming (Baker-Austin et al., 2012). V. vulnificus
switches between free-swimming and sessile life-forms, both establishing particular relationships
with filtering organisms (mainly oysters) and fish (mainly eels), its animal reservoirs in water
(Oliver, 2015). V. vulnificus was defined as a bacterial species in 1976 and was later split into three
biotypes (Bts) on the basis of differences in phenotypic and genotypic traits as well as host range
(Tison et al., 1982; Bisharat et al., 1999).
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The diseases caused by Vibrio species are known as vibrioses.
There are two main forms of human vibriosis related to the
transmission route; contact (type I) or ingestion (type II).
In type I, the pathogen causes severe tissue necrosis after
contact of a wound with seawater or fish that can lead to
debridement/amputation or even secondary septicaemia (Strom
and Paranjpye, 2000; Jones and Oliver, 2009). Since people that
suffer human vibriosis type I are usually swimmers, bathers and
fishers, this pathogen is sometime known as the “marine flesh-
eating bacterium.” In type II, the pathogen causes gastroenteritis
or primary septicemia after ingestion of raw seafood. The
common characteristic to both vibrioses is that they can lead
to sepsis with a probability of death strongly dependent on
iron levels in patient’s blood (Feldhusen, 2000; Jones and Oliver,
2009; Horseman and Surani, 2011), being >50% in patients with
hemochromatosis or other iron overload conditions (Horseman
and Surani, 2011; Arezes et al., 2015). Fish vibriosis is a
haemorrhagic septicaemia produced by contact with water or fish
(carrier or diseased) without a relationship with high iron levels
in blood (Amaro et al., 2015). The common feature of fish and
human vibrioses is that the pathogen invades the blood causing
sepsis. Regarding Bts, all three can cause human vibriosis but only
Bt2 is also able to cause fish vibriosis, an ability that relies on
a plasmid which encodes a resistance system to the fish innate
immunity (Amaro and Biosca, 1996; Lee et al., 2008; Valiente
et al., 2008b; Amaro et al., 2015). Further, among Bt2 strains,
only those belonging to clonal complex Bt2-SerE (serovar) are
recognized as being truly zoonotic (Amaro and Biosca, 1996;
Sanjuán et al., 2011).
Among all the V. vulnificus virulence factors, the RtxA1
toxin seems to be the most relevant, as it is the one present
in the majority of clinical strains (Satchell, 2011, 2015; Lee
et al., 2013; Kim et al., 2015). In the case of human vibriosis,
RtxA1 was proposed to be involved in innate immune evasion
in subcutaneously infected mice (model for type I vibriosis;
Lo et al., 2011) as well as in intestinal epithelium destruction
plus blood invasion in intragastrically infected mice (model for
type II; Kim et al., 2008; Jeong and Satchell, 2012). In the
latter model, it seems that the major hemolysin produced by
the three Bts of V. vulnificus, VvhA, could have an additive
effect on RtxA1 (Jeong and Satchell, 2012). In the case of
fish vibriosis, RtxA1 is involved in both defense against innate
immune cells (phagocytosis experiments with primary cultures of
eel’s neutrophils) and animal death (virulence experiments in eels
infected by intraperitoneal [i.p.] injection or immersion) (Callol
et al., 2015a,b).
V. vulnificus RtxA1, or MARTXVv, belongs to the subfamily
of Multifunctional Autoprocessing Repeats-in-toxins (Fullner
Satchell, 2007; Satchell, 2011, 2015). MARTX toxins present
two common external modules containing the repeat sequences,
together with a variable internal module containing a unique
combination of functional domains responsible for the toxic
action. The toxin is secreted after bacterium-cell contact and it
associates to the eukaryotic cell membrane where the external
modules form a pore for translocation of the internal module to
the cytoplasm. Later, the toxin autoprocesses and the domains
are liberated into the cytoplasm. Seven types of MARTXVv and
nine functional domains have been described so far (Satchell,
2015). The molecular function of eight out of these nine domains
has been demonstrated by Dr. Satchell’s laboratory (Antic et al.,
2015; Dolores et al., 2015; Kim et al., 2015; Satchell, 2015; Agarwal
et al., 2015a,b) (Figure 1). All MARTXVv seem to act as cytolysins
in vitro but differ in the mechanism of cell destruction, which
probably relys on the precise domain combination (Satchell,
2015). With the exception of Bt2, there is no relationship between
RtxA1 type and Bts. Figure 1 shows the two main MARTXVv
types. RtxA11 (or MARTX type I) is present in the most virulent
Bt1 strains and its mode of action has been extensively studied
(Lee et al., 2007; Liu et al., 2007; Kim et al., 2008, 2015; Kwak et al.,
2011; Lo et al., 2011; Jeong and Satchell, 2012; Satchell, 2015).
In contrast, RtxA13 (or MARTX type III) is still uncharacterized.
Interestingly, rtxA13 is duplicated in the pVvBt2 plasmid and the
chromosome II of Bt2 strains.
The present work is focused on RtxA13 and its hypothetical
role in vivo as a virulence factor involved in both human and
fish sepsis. Our hypothesis is that once the bacterium arrives in
blood, and only if it is able to resist the bactericidal/bacteriostatic
action of serum, the bacterium multiplies, liberates the toxin
after its interaction with blood cells, and triggers a cytokine (CK)
storm that could be fatal. This hypothesis is based on the results
obtained in the eel; fish i.p.-infected with mutants deficient in
both copies of the toxin were colonized internally and externally
by the mutant but they the eels did not develop vibriosis (Lee
et al., 2013). Further, there was no statistical differences in
colonization index of internal organs between wild-type and
mutant strains (Lee et al., 2013), and bacterial numbers were far
below those characteristic for other fish pathogenic Vibrio spp.
(i.e., V. anguillarum).
To demonstrate this hypothesis, we selected the Bt2-SerE
wild-type strain CECT 4999 (R99) and its derivative mutant
R9911rtxA13, which lacks the two copies of rtxA13, and
generated three new mutants, one deficient in the ACD-domain
(the only uncharacterized domain inV. vulnificus) (R9911ACD)
in vvhA (R991vvhA) and in both toxins (R9911rtxA131vvhA).
We included in the study strain YJ016, a Bt1 human isolate
that produces RtxA11 (Bt1-RtxA11; Chen et al., 2003) as
representative of the most virulent lineage (Cohen et al.,
2007; Sanjuán et al., 2011), as well as its derivative mutant
YJ0161rtxA11 for comparative purposes. The strains were used
in the following assays: (i) in vitro assays to determine the
molecular action of the ACD domain and the type of cell death
associated to RtxA13; (ii) ex vivo assays to compare growth in
human blood/serum of Bt1-RtxA11 and Bt2 strains as well as
to follow the transcription of rtxA11, rtxA13, and vvhA; and
(iii) in vivo assays in an animal model of sepsis, in which we
determined the virulence degree of the wild-type strain vs. each
one of the mutants and followed the transcription in blood of 84
host immune-related genes.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Growth
Conditions
The bacterial strains and their characteristics are listed in
Table 1. Bacteria were routinely grown on Tryptone Soy agar
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FIGURE 1 | Schematic representation of type III and type I MARTX toxins, and function of each domain.
TABLE 1 | Strains used in this study.
Designation Description Isolation source/References
V. vulnificus
CECT 4999* (R99) Biotype 2, serovar E (Bt2-SerE) Diseased eel (Spain) (Lee et al., 2008)
YJ016** Biotype1 (Bt1-RtxA11) Taiwan (1993) (Chen et al., 2003)
R9911rtxA13 CECT4999 rtxA13-defective mutant. Lacks both plasmidic and chromosomic copies Lee et al., 2013
R991vvhA CECT4999 vvhA-defective mutant This study
R9911ACD CECT4999 ACD domain-defective mutant This study
R9911rtxA131vvhA CECT4999 rtxA13 and vvhA-defective mutant This study
YJ0161rtxA11 YJ016 rtxA11-defective mutant Lo et al., 2011
E. coli
DH5α SupE44 lacU169 (ϕ80 lacZM15)hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Hor et al., 2000
S17-1λpir Thi thr leu tonA lacy supE recA::RP4-2-Tc::Mu Km/λpir Hanahan, 1983
*CECT 4999 (Spanish Type Culture Collection or CECT). **YJ016 [Dr. L-I Hor collection; originally isolated in the National Cheng-Kung University Hospital (Taiwan)].
supplemented with 0.5% NaCl (TSA-1) at 37◦C for 24 h. Prior to
mouse infection, the colony morphology on TSA-1 was checked
to confirm its opaque morphology (V. vulnificus shifts between
opaque (capsulated) and translucent (acapsulated) morphotypes,
as acapsulated cells are avirulent for mice (Simpson et al., 1987).
All strains were stored in LB-1 plus glycerol (17%) at−80◦C.
The inoculum for ex vivo and in vivo assays was prepared as
follows: one opaque colony was seeded in LB-1 (Luria-Bertani
broth, 1% NaCl) and bacteria were incubated at 37◦C with
shaking (100 rpm) up to mid-exponential growth phase. These
bacterial cells were immediately used.
Generation of the R9911ACD, R991vvhA,
and R9911rtxA131vvhA Mutants
All mutants were generated by in vivo allelic exchange as
described previously (Shao and Hor, 2000). Briefly, to generate
R991vvhA and R9911rtxA131vvhA mutants, DNA fragments
from the vvhA down- and up-stream regions were amplified
with the primer pairs vvhA-1/vvhA-2 and vvhA-3/vvhA-4
(Supplementary Table 1), respectively. Both fragments were
sequentially cloned into pGEMT R©-easy vector (Promega) and
then transformed into DH5α to generate a recombinant fragment
containing a 1,380 bp-deletion within vvhA. This recombinant
fragment was removed from the pGEMT R©-easy vector by
enzymatic digestion at the two XmnI sites, and cloned into the
suicide vector pCVD442. The recombinant suicide plasmid was
transformed into E. coli S17-1λpir and then transferred into
R99 or R991rtxA13 by conjugation to generate the mutants
by allelic exchange. Similarly, to construct the R9911ACD
derivative, DNA fragments from the ACD down- and up-
stream regions were amplified with the primer pairs gp018/gp019
and gp020/gp021 (Supplementary Table 1), respectively, and
then cloned into pUC19 between SacI and XbaI sites. This
recombinant fragment, containing a 1,392-bp deletion in ACD,
was removed by SacI and XbaI enzymatic digestion and then
cloned into pCVD442. The resultant recombinant vector was
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transformed into E. coli S17-1λpir and subsequently transferred
into R99 by conjugation to generate the mutant by allelic
exchange. All mutants were confirmed by PCR and sequence
determination.
In vitro Experiments
Cell Lines, Growth Conditions, and In vitro Infection
The cell lines, THP-1 (human peripheral blood monocytes,
ATCC reference number TIB-202) and ECV304 (human vascular
endothelial cells, ATCC reference number CRL-1998) were
obtained from the Cell Culture facility of the University of
Valencia (Spain). THP-1 cells were maintained as suspension
cells in Roswell Park Memorial Institute Medium (RPMI-1640,
Biowest Europe) supplemented with 10% FBS (fetal bovine
serum, Biowest Europe) plus 1% P/S solution (penicillin-
streptomycin stock, Biowest Europe), and ECV304 cells were
maintained as adherent cells in DMEM (Dulbecco’s Modified
Eagle’s Medium) supplemented with 10% FBS plus 1% P/S, in
both cases at 37◦C and 5% CO2. Three hours or 24 h prior to
infection, respectively, cells were seeded in tissue culture plates (5
× 105 cells mL−1) containing serum and antibiotic-free DMEM
(serum-starvation conditions). Cells were then infected with
washed bacteria from exponential cultures in serum-free DMEM
at different MOIs (multiplicity of infection; bacteria:human cell).
Cell damage assay
Supernatants from infected ECV304 were harvested and cell
damage induction was determined by lactate dehydrogenase
(LDH) release using the Cytox 96 Non-Radioactive Cytotoxicity
Assay kit (Promega) according to manufacturer’s instructions. A
recombinant bovine LDH (Sigma-Aldrich) was used to generate
a standard curve and sample values were extrapolated from the
curve.
Detection of Actin Polymerization by Western Blotting
Infected THP-1 and ECV304 cells were lysed using a modified
RIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1
mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS) containing 1X HaltTM Protease & Phosphatase Inhibitor
cocktail (Sigma-Aldrich). The lysate was incubated on ice for
30 min and centrifuged for 10 min in a refrigerated microfuge.
Supernatants were assayed for total protein using the BCA
Protein Quantitation kit (Pierce, Thermo Scientific). Protein
(15µg) was separated on a 12% SDS-PAGE gel before transfer
to an Immun-blot PVDF membrane (Roche Diagnostics).
Membranes were incubated with anti-human α-actin primary
(1:5000 dilution; Millipore) and secondary (1:10,000 dilution;
Sigma-aldrich) antibodies and developed using Lumi-light
Western Blotting substrate (Roche Diagnostics).
Necrosis/Apoptosis Assay by Flow Cytometry
Infected THP-1 cells were collected, washed twice with PBS and
stained with Annexin-V and Propidium iodide (PI) using the
FITC Annexin V Apoptosis Detection Kit I (BD Pharmingen),
according to manufacturer’s instructions. Apoptosis/necrosis
induction was then measured by Flow cytometry using a
FACSverse flow cytometer (BDbiosciences).
In vivo Experiments
Animal Model of Sepsis: Mean Lethal Dose
Determination (LD50) and Immune-Response Assays
The bacterial virulence for mice was determined in 6- to 8-
week old female (mice BALB/c, Charles River, France) by i.p.
injection with ten-fold serially diluted bacterial suspensions in
PBS. Mortalities were recorded only if the inoculated bacterium
was recovered in pure culture from kidney or liver of moribund
animals. The LD50 was calculated as described (Reed and
Muench, 1938).
To determine the immune response during sepsis, groups
of 6–8-week-old female were i.p. injected with 1 × 106
CFU/mouse, and mice were anesthetized at 2, 4, or 6 h post-
infection. Blood was collected by cardiac puncture and samples
were stored in RNA later at 4◦C until RNA extraction. PBS-
injected mice were used as controls. After blood extraction,
mice were sacrificed and the spleen and liver were obtained to
microbiologically confirm bacterial invasion. To this end, spleens
and livers were mechanically disaggregated in 1 mL of PBS. The
homogenate was inoculated completely into LB-1 media and was
incubated overnight at 37◦C with shaking. In parallel, a loop
of the homogenate was directly streaked onto TSA plates. After
incubation, 0.1 mL of the LB-1 culture was spread onto TSA-
1 plates. All seeded TSA-1 plates were incubated at 37◦C for
24 h. Plates were examined to confirm purity of the culture
and randomly selected colonies were purified and serologically
identified by agglutination with previously obtained specific anti-
YJ016 or anti-R99 rabbit polyclonal antibodies.
Murine RNA Processing for Gene Expression Analysis
Total RNA was isolated using the Mouse RiboPureTM -Blood
RNA Isolation Kit (Invitrogen, Thermo Fisher Scientific) and
treated for 45 min at 37◦C with Turbo DNaseTM (Ambion R©,
Life Technologies). The concentration and purity of each
RNA was checked in a Nanodrop 2000 Spectrophotometer
(Thermo Scientific). To check the absence of genomic DNA,
real-time qPCR was performed on the RNA samples by using
Power SYBR R© green PCR Mastermix (Applied Biosystems R©,
Life Technologies) and B2m and Gusb primers. The Real-
time qPCR was performed on a StepOnePlusTM Real-Time
PCR System (Applied Biosystems), with the primers were
taken from Primerbank. RNA from each mice group was then
pooled after discarding samples that presented low quality/gDNA
contamination. An RNA pool from a minimum of 3 animals
was used to obtain the cDNA. The cDNA was transcribed from
total RNA using All-in-OneTM First-Strand cDNA Synthesis Kit
(GeneCopoeiaTM).
Murine Gene Expression Analysis by qPCR Array
To assess the global immune response activated by V. vulnificus
during an in vivo infection, we designed a specific qPCR
array for profiling the expression of 84 immune-related genes
(Supplementary Table 2) (ExProfile Custom Gene qPCR Array,
GeneCopoeiaTM). The PCR array included probes for genes
involved in the general immune response against bacteria as
well as genes involved in the specific immune response in
eels against V. vulnificus (Callol et al., 2015b & Unpublished
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results). The selected genes included: 12 genes for CCs, 18 genes
for CKs, 8 genes related with the IFN response, 5 genes for
transcription factors, 15 genes for pathogen recognition receptors
(PRRs) and other cell receptors, 8 genes for signaling proteins, 5
genes related with the inflammasome response and 13 additional
genes that included genes for complement proteins, apoptosis
related genes, iron starvation, etc. (Supplementary Table 2).
Real-time PCR was performed on cDNA using All-in-One
TM
qPCR Mix (GeneCopoeiaTM) and the customized Gene qPCR
Array (GeneCopoeiaTM), on a StepOnePlusTM Real-Time PCR
System. The threshold cycle (CT) values were determined to
establish the relative RNA levels of the tested genes, and the
fold-change in gene expression of V. vulnificus infected mice
compared with uninfected control mice was calculated using
the GeneCopoeia analysis tool for custom arrays. Six different
housekeeping genes included in the array (Supplementary
Table 2) were used in the analysis. Each treatment (strain and/or
infection time) was performed twice, on separate days, and
assessed in two different arrays independently, before being
analyzed together as replicates with the GeneCopoeia analysis
tool.
Expression of rtxA13 In vivo
The expression of rtxA13 and vvha genes was also determined
in the blood samples from V. vulnificus R99 infected mice. The
real-time qPCR was performed on the same cDNA samples
used for the customized gene qPCR array. Real-time PCR was
performed on cDNA using Power SYBR R© green PCRMastermix
on a StepOnePlusTM Real-Time PCR System. The CT values
were determined with StepOne Software v2.0 to establish the
relative RNA levels of the tested genes, using recA gene as
housekeeping gene. In Bt2-SerE infected mice, the value of
expression of each gene in mice infected for 2 h was set equal to
1, and then the fold increase in gene expression was calculated
in mice infected for 4 and 6 h. In Bt1-RtxA11 infected mice,
the value of expression of rtxA11 in mice infected with the
YJ0161rtxA11 mice was set equal to 1, and then the fold increase
in gene expression was calculated in mice infected with the YJ016
strain. The bacterial primers used are listed in Supplementary
Table 1.
Analysis of Data
We created Venn diagrams using the software available at http://
bioinformatics.psb.ugent.be/webtools/Venn/ (Bioinformatics
and Evolutionary Genomics group at Ghent University). Heat
maps were created using the free software MultiExperiment
Viewer (MeV), available at http://mev.tm4.org/. For PCA, we
created a correlation matrix using Past v3.13 program (Hammer
et al., 2001). Then a 3D graph was generated using the excel
macro “Excel 3D Scatter Plot’ v2.1”, available at http://www.
doka.ch/Excel3Dscatterplot.htm.
Ex vivo Experiments
Model for Hemochromatosis (hm)
The ex vivo model for hm consisted of supplementing
commercial human serum (Sigma-Aldrich, Spain) with FeCl3 at
a final concentration of 10µM (iron content within the range
of those typical of hemochromatosis) (Bacon et al., 2011) (hm-
serum). Then, hm-blood was prepared by resuspending human
blood cells in hm-serum. To this end, whole human blood
was obtained from volunteers recruited from the University of
Valencia. Blood was collected by venipuncture using lithium
heparin tubes (BD Vacutainer R©, BD Biosciences). Blood cells
were separated by centrifugation, erythrocytes were lysed with
ACK buffer (0.15 M NH4Cl, 1 0mM KHCO3, 1 mM EDTA),
and the number of blood cells was determined by microscopic
counting. Finally, 2.5 × 106 blood cells were resuspended in
150µl of hm-serum.Hm-blood and hm-serumwere immediately
used.
Hm-Serum Resistance and rtxA13 and vvha
Expression in hm-Blood
Growth in normal and hm-serum was performed by inoculating
R99 or YJ016 cells at a MOI (multiplicity of infection; bacteria:
human cell) of 2, and taking samples for bacterial counts on
TSA-1 plates at 0, 2, 4, and 6 h. rtxA11 and rtxA13 expression
was followed in normal and hm-blood by taking samples at
the same time intervals. Cells were pelleted and the RNA was
isolated. Different RNA isolation kits were tested beforehand, and
the GenEluteTM Mammalian Total RNA Miniprep Kit (Sigma-
Aldrich) was found to produce higher yields and better RNA
purity. RNA was treated with Turbo DNaseTM, and cDNA
was transcribed from total RNA using random hexonucleotide
primers (Takara Bio Europe), and MaximaTM H Minus Reverse
Transcriptase (Thermo Scientific). Real-time PCRwas performed
and analyzed as described above, and the bacterial primers used
are listed in Supplementary Table 1.
Ethics Statement
Whole human blood was obtained from healthy volunteers
recruited among the staff of the Microbiology & Ecology
Department from the University of Valencia. Donors gave
their written informed consent to participate in the study, in
accordance with the Declaration of Helsinki. They completed a
health questionnaire, and doctor’s consent for their inclusion in
the study was obtained. Only healthy donors were considered;
volunteers with anti-inflammatory or immunosuppressive
prescribed medication, diabetes mellitus, chronic inflammatory
disease, or symptoms of recent infection were excluded.
Volunteers were recruited specifically for the purpose of this
experiment, and blood was collected at the Burjassot campus
medical service of the University of Valencia. Assays were
approved by the Institutional Committee on Human Research
(project license H1487946643442).
All assays involving mice were approved by the Institutional
Animal Care and Use Committee and the local authority
(Conselleria de Agricultura, Medio Ambiente, Cambio Climático
y Desarrollo Rural. Generalitat Valenciana), following European
Directive 2010/63/EU and the Spanish law “Real Decreto”
53/2013. Murine infections were performed under the project
licenses 2014/VSC/PEA/00195 and 2016/VSC/PEA/00069, and
were carried out in the Research Animals core facility of the
University of Valencia.
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The experiments performed in this study are part of the
working plan that was approved and supported by the Ministry
of Economy Industry and Innovation (MINECO) of Spain: Grant
AGL 2014-58933-P.
RESULTS
RtxA13 but Not VvhA Is Involved in
Virulence for Mice
The LD50 of R99 (Bt2-SerE) and YJ016 (Bt1-RtxA11) strains
was identical (1 × 106 CFU/mouse or 5 × 104 CFU/gr). The
deletion of vvhA in R99 strain did not change LD50 value,
while the deletion of both copies of rtxA13, or both copies plus
vvhA, caused an increase in more than 2 logarithmic units of
the LD50(>10
8 CFU/mouse). Previously, our group had shown
that the double revertant strain (with both copies of rtxA13 re-
introduced) had the same virulence level in C3H/HeNmice as the
wild-type strain, confirming that the reduction in virulence of the
RtxA13 mutant was not caused by an unexpected mutation that
had occurred elsewhere (Lee et al., 2013). These results suggest
that RtxA13 but not VvhA is involved in mouse death caused by
Bt2-SerE strains.
RtxA13 Is a Toxin with Actin-Cross-Linking
Activity, Responsible for Early Death of
Human Endotheliocytes and Monocytes
In vitro
RtxA13 from Bt2-SerE has been reported to be involved in
early cell death (Lee et al., 2013). To eliminate the possibility
that VvhA could interfere with RtxA13 in Bt2-SerE, we
infected human vascular endotheliocytes (ECV304 cell line) and
monocytes (THP-1 cell line) with R99 strain and its derivative
mutants (R9911rtxA13, R991vvhA, R9911rtxA131vvhA) and
incubated the infected cells for 6 h. The R99 strain started
to lyse cells before 4 h post-infection (hpi) with a maximum
at 5 h that was maintained up to 6 hpi, without significant
differences with R991vvhA strain at any sampling point. In
contrast, there were significant differences in cell lysis between
R99 and R9911rtxA13 strains at 4 and 5 hpi, and between R99
and R9911rtxA131vvhA strains at 4, 5, and 6 hpi (Figure 2A).
Similar results were obtained by infecting human monocytes
(data not shown). Taken together, our results suggest that both
toxins do not overlap at short term (before 6 hpi), with RtxA13
the main factor responsible for early cell lysis caused by Bt2-SerE
in vitro. Finally, a light lytic effect was also found at 6 hpi when
the mutant in both toxins was tested, indicating that other toxins
apart from RtxA13 and VvhA could also produce cell death in
vitro.
To find out if RtxA13 could cause cell death by apoptosis, we
analyzed it by flow cytometry (Figure 2B and data not shown).
After 3.5 h of in vitro infection of human monocytes, the
percentage of cells in late apoptosis (stained with both annexin
V and PI) was close to 100% in the wild-type strain, whereas
only 27% of the cells were in this stage after being infected with
the rtxA13 mutant (Figure 2B). No evidence of cell death by
apoptosis was observed in endothelial cells (data not shown).
This result suggests that RtxA13 can induce early apoptosis in
human monocytes but not in endotheliocytes cultured in vitro.
RtxA13 contains an ACD domain that is predicted to have
actin cross-linking activity due to its high similarity with the ACD
domain of MARTX of V. cholerae (Sheahan et al., 2004; Kwak
et al., 2011; Roig et al., 2011). Thus, we next sought to determine
if the ACD domain and, in consequence, RtxA13, could also have
this activity by infecting human monocytes and endotheliocytes
with R99, R9911rtxA13, and R9911ACD strains and detecting
actin cross-linking by western blotting (Figure 3). As early as 1
hpi, R99 strain induced the formation of actin oligomers that
was dependent on the infection dose, and progressed with the
infection time (Figure 3). Thus, at 3 hpi, any native actin (42 Kda)
was left in the samples had all been converted to an oligomer
of ∼250 KDa (Figure 3). As expected neither R9911rtxA13
nor R9911ACD strains induced actin polymerization, at any
sampling point. All these results proved that ACD domain of V.
vulnificus and, in consequence, RtxA13, has actin-cross linking
activity.
We also tested if this domain was essential to induce apoptosis
in human monocytes (Figure 2B). The mutant in the ACD
domain produced the same degree of apoptosis as the wild-
type strain, which suggests that this domain is not involved in
apoptosis of human monocytes in vitro.
V. vulnificus Bt2-SerE R99, but Not
Bt1-RtxA11 YJ016, Induces an Early and
Strong Immune Response in Mice
In order to test if V. vulnificus Bt2-SerE induces an early and
strong immune response in mice that could be compatible with
a CK storm (CKS), we analyzed the transcription of 84 murine
genes in blood from infected and non-infected mice by using a
sepsis model of infection. We also inoculated mice with YJ016
for comparative purposes.
Prior to the expression analysis, we checked that the
inoculated strain had colonized the infected animals internally
by isolating it from spleen, liver, and blood. Both strains were
recovered in pure culture from all the internal organs of the
infected mice but only after enrichment, which prevented us
from calculating an organ colonization index. No bacteria were
recovered from internal organs of non-infected mice.
Then, we determined murine DEGs (differentially expressed
genes) in response to each of the strains by comparing data
between infected and non-infected mice. Results are summarized
in Figures 4, 5.
The immune response against R99 strain was very fast and
strong, and remained over time: it included 56 out of the 84
selected genes (67%), all of them up-regulated (Table 2), from
which 21 (out of 56 or 37.5%) were already up-regulated at 2
hpi, and 16 of them (out of 21, or 76.2%) continued to be up-
regulated at 6 h (Figure 4). The core DEGs (genes up-regulated
at all time points) contained genes for: (i) two interleukins with a
strong pro-inflammatory and immune-regulatory activity (Il1a,
Il1b) plus their receptor (Il1r2) and its agonist (Il1rn); (ii) four
CKs and chemokines (CCs) (Ccl4, Il3, Il4, and Il17a); (iii) one
type I interferon (IFN) (Ifnb1); (iii) Nfkb1, a subunit of the
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FIGURE 2 | V. vulnificus rtxA13 gene is involved in cell damage induction and apoptosis in human monocytes. (A) Live cells of V. vulnificus R99, R9911rtxA13
mutant, R991vvha mutant, and the double R9911rtxA131vvhA mutant, were added at a MOI of 2 to ECV304 cells. Cells were incubated with the bacteria for the
appropriate time intervals and then cell culture supernatants were collected and assessed for lactate dehydrogenase (LDH) levels. Data represent mean values ±
standard deviation from three independent experiments. The significance of the differences was determined using the Student’s two-tailed t-test; *p < 0.05 and **p <
0.01 compared with R99 infected cells. (B) THP-1 cells were infected for 3.5 h with V. vulnificus R99, R9911rtxA13, and R9911ACD strains, at a MOI of 10. The
induction of apoptosis/necrosis was then measured by Flow Cytometry using the FITC Annexin V Apoptosis Detection Kit I. Results show histograms from one
representative experiment of two.
transcription factor complex NF-κB; (iv) Tlr9, an intracellular
PRR that recognizes CpG motifs of microbial DNA; (v) Dusp1
(MKP-1), the dual specificity protein phosphatase 1, a key
phosphatase involved in a negative feedback loop regulating
the MAPK pathway; (vi) Ank1, a protein with roles in cell
motility, proliferation or cell contact; (vii) C4b, the complement
component 4; (viii) Kras, a GTPase; and, ix) Nos2, the inducible
nitric oxide synthase.
Among the DEGs that were up-regulated exclusively at 4 h
were genes for: (i) another type I IFN (Ifna2) and its receptor
(Ifnar1), the receptor for IFN-γ (Ifngr1) and an IFN regulatory
factor (Irf1); (ii) one CC involved in the recruitment and
activation of granulocytes (Cxcl3) and two pro-inflammatory
CKs (Il7, Lta); (iii) three proteins of the inflammasome complex
(Nlrc4, Pycard, and Casp1); (iv) two transcription factors (Jun
and Rela); (v) four PRR and receptors (Tlr2, Cd14, Nod2, Cd82)
and (iv) other genes such as, Tfrc, the transferrin receptor
(Figure 4).
Finally, at 6 hpi there were still 32 genes up-regulated (out of
56, or 57%), 8 of them exclusively at this time. These included
the genes for: (i) the CCs CCL3 (MIP-1α) and CCL5 (RANTES),
involved in the recruitment and activation of different immune
cells; (ii) the CXC CCs, CXCL1, and CXCL2, which are chemo-
attractant for neutrophils, granulocytes and hematopoietic stem
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FIGURE 3 | Role of the ACD domain in actin polymerization. V. vulnificus R99, R9911rtxA13, and R9911ACD cells were added at MOIs of 1 and 5 to THP-1
suspension cells and ECV304 adherent cells for 1, 2, and 3 h. Cell lysates were separated by SDS-PAGE and western blotted to detect polymerization of α-actin.
Data are representative of two independent experiments.
cell, respectively; (iii) the C-type lectin CLEC4D; and (iv) LCN2,
a protein that limits bacterial growth by sequestrating iron.
The maximum number of up-regulated genes was reached at
4 hpi, at which time a total of 47 genes were activated (Figure 4).
For that reason, we selected this time point for the immune
response analysis against the selected Bt1- RtxA11 strain.
Strain YJ016 induced a completely different immune response
that involved a higher number of DEGs (76 vs. 47) most of them
down-regulated (Figure 5). Thus, only 29 out of 76 genes were
up-regulated, 14 in common with strain R99 (Figure 5B). Again,
the genes for IL-1α, IL-1β, and the IL-1 receptor, belonging to
the IL-1 family, were up-regulated, stressing its importance as
an immune-mediator system against any V. vulnificus strain.
Also, the genes for the CK IL-6 and for the CCs CXCL3 and
PF4 (or CCXL4) were up-regulated. PF4 showed the highest
value of fold-change, 232, a value that was significantly higher
than the one induced by strain R99 (2- and 22-fold-change at
4 and 6 h, respectively) (Table 2). PF4, a CXC CC produced by
activated platelets during its aggregation, has a large number of
biological effects such as, activation of different immune cells
(NK cells, T cells, monocytes, and granulocytes), differentiation
and chemotaxis, inhibition of endothelial cell migration, a dual
pro- and anti-coagulant effect mediated by platelet-aggregation
potentiation (Sandset, 2012) and Protein C activation (Slungaard
and Key, 1994), respectively. Other genes induced by both
strains were the IFN regulatory factors Irf1 and Irf2, the
lipopolysaccharide receptors Tlr4 and Cd14, and Dusp1.
Among the genes uniquely induced by YJ016 strain were Ccl2
and Tnfα (Figure 5B). Remarkably, the pattern of induction of
PRRs was very different between both strains; YJ016 induced
strongly the expression of the C-type lectin genes Clec4d and
Clec4e, and Syndecan-4 (Snd4) whereas R99 induced Tlr2 and
genes for intracellular receptors such as, NOD2 (located in
the cytoplasm and recognizing muramyl dipeptide from gram-
positive and negative bacteria; Kawai and Akira, 2009) and
TLR9. Indeed, the genes for these two intracellular receptors
were down-regulated by YJ016 strain (Figure 5C). There were
also other genes up-regulated by YJ016 strain at 4 hpi that
were not induced by the R99 strain at this time point, but
that were induced by the R99 strain at 2 or 6 hpi, such as,
Ccl3, Ccl5, Ccl6, Cxcl1, Cxcl2, Mapk6, Mapk8, and Lcn2, which
was strongly up-regulated by both strains (Figures 4, 5, and
Table 2).
Taking a closer look at the genes down-regulated by strain
YJ016 (Figure 5C), we found genes that were up-regulated
by the R99 strain, such as, the transcription factors genes
Fos, Jun, Nfkb1, and RelA, a number of CCs and CKs genes
(Il1rn, Il3, Il4, IL7, IL17a, Csf2, Lta), IFN related genes
(Ifna2, Ifnb1, Ifnar1, and Ifngr1), and the genes that encode
proteins for the inflammasome complex (Nlrc4, Aim2 and
Casp1).
Comparing the global results, it can be concluded that R99
but not strain YJ016 induces an early and strong inflammatory
response that could be compatible with a CKS.
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FIGURE 4 | V. vulnificus Bt2-SerE R99 strain induces the early up-regulation
of a large number of immune-related genes. Venn diagram depicting the
overlap of the 56 immune-related genes that are differently up-regulated
between R99 strain infected-mice for 2, 4, or 6 h, when compared with
uninfected mice. Only genes up-regulated more than 1.3 were considered.
RtxA13, but Not RtxA11, Induces a Strong
Early Immune Response against
V. vulnificus in Mice
We hypothesized that RtxA13 is a key virulence factor in sepsis.
To examine this, we compared the immune response of mice
against strain R99 and its derivative mutant R9911rtxA13 at 4
hpi. In parallel, we also compared the immune response of mice
against strains YJ016 and YJ0161rtxA11.
Prior to RNA analysis, we checked again the colonization
process of internal organs by isolating the inoculated strain from
spleen and liver of infected mice. Again, we recovered pure
cultures of all the strains, including both mutants, from all the
organs and sampling times, but only after enrichment.
In parallel, we checked that rtxA13 and rtxA11 were being
expressed in vivo at 4 hpi, a time at which blood was sampled
for transcription analysis. As expected, both bacterial genes were
transcribed in vivo although with different fold-change values
(average fold-change of 2.5 [rtxA13] vs. 4.8 [rtxA11]). In addition,
we followed the time course of rtxA13 and vvhA transcription to
discard the possibility that both toxins could act together in vivo
at the selected sampling time. rtxA13 was detected at 2 hpi, being
up-regulated at 4 (average fold-change of 2.5) and 6 (average fold-
change of 3.0) hpi, while vvhAwas only induced at 6 hpi although
with a higher fold-change (average fold-change 4.0). These results
prove that of the two toxins, only rtxA13 is relevant at 4 hpi.
We then compared the immune response generated by each of
the wild-type strains with that induced by its mutant (Figure 6).
The R99 strain specifically induced the expression of a large
number of genes (32) including those for CKs (Il3, Il4, Il6,
Il7, Il17a, Csf2, and Lta), for IFN-related proteins (Ifna2, Ifnb1,
Ifnar1, and Ifngr1), for inflammasome components (Nlrc4 and
Casp1) and for a large number of transcription factors (Fos,
Jun, Junb, Nfkb1, and Rela) (Figure 6A). In contrast, there were
significantly fewer differences between the responses generated
by the wild-type YJ016 strain and its mutant (Figure 6B);
only 13 genes were induced by the wild-type strain and not
by the mutant, and the great majority of them (9/13) were
also induced by the R99 strain, the R9911rtxA13 mutant,
or both (Ccl3, Cxcl1, Cxcl2, Cxcl3, Il1a, Il6, Cd14, Tlr4,
and C3). The strong pro-inflammatory response induced by
the R99 strain and not by its mutant would suggest that
the activation of the CKS was mainly due to the RtxA13
toxin.
We then globally compared the results of the qPCR array
from the 4 groups of inoculated animals by performing a Heat
Map (Figure 7). The pattern of gene expression induced by both
YJ0161rtxA11 and R9911rtxA13 strains was very similar, with a
significant number of genes down-regulated (Figure 7). Further,
the pattern of gene expression induced by both rtxA1 mutants
was more similar to the one induced by YJ016 strain than to the
one induced by strain R99 (Figure 7).
Only 7 out of the 84 selected genes were up-regulated by
all four strains; (i) Il1b and Il1r2; (ii) the genes for the IFN
regulatory factors IRF1 and IRF2; (iii)Dusp1 andMapk1; (iv) Sell,
encoding L-selectin, a cell surface adhesion molecule required
for binding and subsequent rolling of leucocytes on endothelial
cells, facilitating their entry into secondary lymphoid tissues and
inflammation sites; (v) Tfrc, encoding the transferrin receptor;
and (v) PF4. This latter gene was by far the one most up-
regulated, reaching a 433-fold increase (Table 2).
To comprehensively analyse the results, we performed a
Principal Component Analysis (PCA) using the data from the
mice infected with the wild-type strains and their correspondent
mutants, all examined at 4 hpi. As shown in Figure 8A, the
analysis confirmed that the immune responses against YJ016
and R99 were clearly different and that the responses against
both rtxA1 mutants were very similar, regardless of the strain
that harbored the mutation. Further, the response against
R9911rtxA13 was more similar to the one against YJ016 strain
than to the one against its own parental strain (Figure 8A), which
suggests that the strong immune response against strain R99 was
mainly due to RtxA13.
Finally, we repeated the PCA, including the data from the
mice infected with strain R99 and analyzed at 2 and 6 hpi
(Figure 8B). The analysis grouped immune response data into
three clusters; the first corresponding to mice infected with the
two rtxA1 mutants and YJ016 strain, all being analyzed at 4 hpi;
the second group corresponded to mice infected with strain R99
and analyzed at 2 and 4 hpi; and the third group corresponded to
mice infected with strain R99 and analyzed at 6 hpi. Curiously,
this last group was closer to the first one (Figure 8B). This last
result, together with the previous ones obtained by PCA, strongly
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FIGURE 5 | Bt1-RtxA11 and Bt2-SerE elicit a different immune response. (A) Number of genes up- and down-regulated in mice infected with the Bt2-SerE R99 strain
and the Bt1-RtxA11YJ016 strain. (B) Venn diagram depicting the overlap of the up-regulated genes in response to R99 and YJ016 strain when compared with
uninfected mice. (C) List of genes down-regulated after the infection with the Bt1-RtxA11 YJ016 strain. In all cases, only genes up-regulated more than 1.3 or
down-regulated more than 0.5 were considered.
suggests that the immune response due to RtxA13 had a peak at
4 h and decreased at 6 hpi.
rtxA11 and rtxA13 Are Expressed in the
Presence of Human Blood Cells as
Determine by an Ex vivo Model of
Hemochromatosis
We used an ex vivo model that simulates sepsis in
hemochromatosis (hm) human patients and followed the
transcription of rtxA1 genes after the co-culture of the bacteria
with human PBMCs (peripheral blood mononuclear cells).
Real time qPCR results showed that the expression of the
rtxA1 gene was up-regulated in both YJ016 and R99 strains
after being in contact with human cells for 2 h. At 4 and 6
hpi, the genes showed similar expression levels as seen at time
0 (Figure 9A). There was a noticeable difference between the
expression of rtxA11 and rtxA13; rtxA13 was up-regulated 12-
fold when compared with time 0, whereas the rtxA11 presented a
smaller up-regulation (around 3.5-fold).
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TABLE 2 | Fold change value of genes when compared with uninfected mice.
R99 YJ016 (4 h) R99 1rtxA13 (4 h) YJ016 1rtxA11(4 h)
2 h 4 h 6 h
CHEMOKINES
Ccl2 0.900 0.990 0.712 2.613 0.616 0.130
Ccl3 0.900 0.990 1.425 21.010 1.748 0.368
Ccl4 10.157 3.940 7.799 1.249 1.181 0.497
Ccl5 0.601 0.986 3.827 4.945 9.320 3.907
Ccl6 5.078 0.702 0.972 2.512 1.666 1.403
Ccl12 0.900 0.990 0.688 0.115 0.148 0.062
Ccl20 0.900 1.008 0.688 0.041 0.151 0.062
Cxcl1 0.882 0.992 2.818 41.006 3.425 0.509
Cxcl2 0.943 1.041 2.864 41.896 3.479 0.518
Cxcl3 0.884 1.404 0.676 41.053 2.404 0.507
Pf4 0.882 2.038 22.307 231.676 433.480 367.456
Cxcr4 5.074 2.798 0.960 1.252 1.665 0.991
CYTOKINES
Il1a 3.612 2.802 2.791 20.162 3.362 0.354
Il1b 1.804 1.983 2.765 20.033 26.816 7.953
Il1rn 1.817 1.993 1.394 0.080 0.301 0.125
Il1r2 1.840 2.035 1.438 7.244 6.848 2.870
Il3 2.540 1.985 1.952 0.056 0.295 0.178
Il4 3.620 1.988 1.371 0.039 0.297 0.088
Il6 1.282 1.992 7.729 2.514 0.420 0.125
Il7 1.276 1.394 0.982 0.056 0.297 0.176
Il12a 0.900 0.990 0.688 0.057 0.148 0.180
Il12b 0.900 0.990 0.688 0.057 0.148 0.064
Il17a 3.602 4.000 1.397 0.111 0.149 0.177
Il18 0.900 1.010 0.688 0.163 0.308 0.259
Csf2 1.841 1.437 0.705 0.160 0.303 0.128
Csf3 0.900 1.013 0.688 0.325 0.151 0.064
Tnf 0.939 1.011 0.721 2.610 1.232 0.520
Lta 0.900 1.426 0.688 0.058 0.152 0.090
Vegfa 0.636 0.700 0.061 0.020 0.075 0.044
Il10 0.446 0.989 0.687 0.039 0.209 0.124
IFN RELATED GENES
Ifna2 0.939 1.441 0.688 0.039 0.221 0.090
Ifnb1 1.822 1.396 2.788 0.040 0.429 0.127
Ifnar1 0.637 1.392 0.976 0.111 0.417 0.176
Ifng 0.900 0.990 0.688 0.116 0.151 0.063
Ifngr1 1.281 1.975 0.487 0.445 0.595 0.354
Irf1 0.919 1.410 0.675 5.167 2.426 1.443
Irf2 0.916 1.397 1.395 2.559 3.403 2.026
Irf7 0.900 0.990 0.688 1.864 1.241 0.520
TRANSCRIPTION FACTORS
Fos 2.573 1.984 0.994 0.079 0.298 0.125
Jun 0.899 1.985 0.689 0.111 0.147 0.124
Junb 0.893 1.403 2.769 0.630 0.833 0.351
Nfkb1 7.268 3.969 1.377 0.080 0.424 0.177
Rela 0.448 1.397 0.682 0.111 0.295 0.175
PRRS AND RECEPTORS
Tlr2 0.428 1.982 0.685 0.626 0.416 0.248
(Continued)
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TABLE 2 | Continued
R99 YJ016 (4 h) R99 1rtxA13 (4 h) YJ016 1rtxA11(4 h)
2 h 4 h 6 h
Tlr4 0.944 2.083 1.435 1.314 1.748 0.735
Cd14 0.900 1.443 0.688 5.219 1.737 0.365
Ly96 0.900 0.987 0.171 0.028 0.104 0.031
Tlr5 0.900 1.008 0.688 0.041 0.215 0.064
Tlr9 3.628 1.989 1.369 0.111 0.596 0.249
Tlr13 0.900 0.990 0.688 0.926 2.464 1.036
Nod1 0.900 0.990 0.688 0.164 0.153 0.184
Nod2 0.945 2.079 0.729 0.234 0.310 0.090
Clec1a 0.900 1.008 0.688 0.039 0.148 0.063
Clec4d 0.937 1.009 1.434 14.828 27.825 11.677
Clec4e 0.900 1.015 0.710 10.415 13.945 4.134
Sdc4 0.652 0.990 0.496 5.073 0.852 0.506
Sell 0.939 1.463 1.426 5.213 6.944 4.130
Cd82 0.893 1.393 0.688 0.224 0.297 0.177
SIGNALING
Mapk1 0.901 1.987 11.020 3.553 6.653 3.968
Mapk3 1.277 1.393 0.974 0.441 1.179 0.495
Mapk6 0.900 0.990 1.431 1.851 3.484 2.069
Mapk8 0.900 1.016 2.865 1.860 2.462 2.084
Mapk14 1.275 1.986 1.968 0.159 0.422 0.175
Dusp1 3.669 1.982 1.406 10.231 4.817 2.025
Traf3 0.900 1.015 0.688 0.233 0.311 0.184
Traf6 7.377 1.440 0.671 0.040 0.430 0.176
INFLAMMASOME
Nlrp3 0.900 0.990 0.688 0.925 0.616 0.183
Nlrc4 0.917 1.428 0.701 0.080 0.151 0.124
Aim2 0.900 1.009 0.688 0.327 0.436 0.733
Pycard 0.635 1.369 0.486 0.883 3.337 1.981
Casp1 0.619 1.398 0.494 0.449 1.200 0.506
OTHER
Ank1 5.078 3.958 1.936 0.111 0.588 0.353
Epb41 1.259 1.966 0.474 0.317 0.595 0.176
C3 0.900 0.990 0.733 5.255 9.860 1.035
C4b 2.549 1.397 1.943 0.881 1.180 0.496
Hc 0.880 1.016 0.673 0.057 0.211 0.088
Casp3 0.888 0.991 0.686 0.440 1.180 0.494
Bax 0.892 0.991 0.689 0.080 0.209 0.088
Kras 1.809 1.978 1.387 0.222 0.593 0.250
Trp53 0.637 0.967 0.465 0.440 0.588 0.496
Lcn2 0.900 1.015 91.646 83.699 111.587 46.747
Tfrc 0.879 1.398 0.700 2.559 4.823 1.435
Nos2 5.117 3.950 1.958 0.055 0.419 0.176
Thbd 0.895 0.988 0.687 0.019 0.070 0.124
Genes up-regulated more than 1.3 or down-regulated more than 0.5 are marked in bold.
V. vulnificus Bt2-SerE Is Unable to
Overcome Blood Iron Restriction
This last result (Figure 9A) was surprising as YJ016 was selected
as a strain representative of the phylogenetic group with the
highest virulent potential for humans (Chen et al., 2003). Thus,
we checked the growth ability of both strains in human serum,
in the presence and absence of a supplemental iron source.
Figure 9B shows that strain YJ016 was equally able to multiply
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FIGURE 6 | Role of RtxA1 in the induction of the host immune response and
CSK. Venn diagram depicting the overlap of the genes that are differently
up-regulated between (A) R99 and R9911rtxa13, and (B) YJ016 and
YJ0161rtxA11 infected-mice for 4 h. Only genes up-regulated more than 1.3
were considered.
in human serum regardless of the presence of supplemental
iron. However, strain R99 was able to grow in the first 2 h of
incubation, but in the absence of supplemental iron its capacity
to multiply disappeared. This finding could explain, at least in
part, the higher virulence potential of this phylogenetic group, as
strain YJ016 could be able to develop sepsis without predisposing
conditions (Chen et al., 2003).
DISCUSSION
The clinical cases of known-etiology associated with the clonal
complex V. vulnificus Bt2-SerE correspond to type I human
vibriosis after fish handling. The hypothesis underlying the
present work refers to the septicemia associated to these vibriosis
cases in humans and is based on previous results obtained
in the eel which related the RtxA13 with animal death by an
early peracute septic shock (Lee et al., 2013). Our hypothesis
predicted that once the bacterium passes to blood from an
infected wound, and only if the bacterium survives in blood, it
would produce RtxA13 that would trigger a CKS resulting in
human death. A CKS in the context of a bacterial septicemia
could be defined as an unbalanced release of pro-inflammatory
and anti-inflammatory CKs in response to the pathogen that
results in a severe pathological damage (Tisoncik et al., 2012).
We found that, effectively, the infection of mice with a Bt2-
SerE strain caused a strong and early CKS that was directly related
to RtxA13 as which was not detected in mice infected with the
mutant deficient in the toxin. This CKS was also related to mice
death, as mice infected with the mutant strain survived despite
being colonized by themutant. In fact, the wild-type strain spread
to the bloodstream and overexpressed rtxA13 in internal organs
as early as 2 hpi, inducing the up-regulation of a significant
number of immune system-related genes. This result was also
obtained in experiments performed in eels (Lee et al., 2013;
Callol et al., 2015a; unpublished results), confirming that Bt2-
SerE exhibits very rapid invasion and rtxA13 in vivo expression,
whatever the infected host is. In accordance again with results
reported in eels (Lee et al., 2013; Callol et al., 2015a), the rtxA13
deficient mutant was able to reach the internal organs (liver and
spleen) so the reduction in immune response intensity was not
due to a lack of bacterial stimulus. The peak of immune gene
activation against the wild-type strain was reached at 4 hpi, at
which time 47 out of the selected 84 genes were up-regulated
while none were down-regulated. At this time, the gene encoding
the main hemolysin produced by this species, vvhA, was not
induced. This result confirmed that VvhA was not interfering
with RtxA13, in contrast to that reported in orally Bt1-RtxA11-
infectedmice where RtxA11 and VvhAwere found to act together
causing pathological damage in the intestine (Jeong and Satchell,
2012).
Interestingly, the CKS induced by RtxA13 included an up-
regulation of immune genes related to the response against
extracellular and intracellular bacteria. This result was quite
unexpected in that all the experiments performed in vivo and in
vitro with strain R99, including those performed in the present
work, have never suggested the existence of an intracellular
stage in the life cycle of this pathogen in any of its hosts.
The unexpected up-regulated genes were for: (i) recognition of
intracellular pathogens, such as, TLR9 and NOD2; (ii) chemo-
attraction of macrophages, natural killer cells, and lymphocytes
such as, CCL4 (MIP-1β; Macrophage inflammatory protein-
1β), a gene that was highly activated at all sampling points,
and that was also early up-regulated in gills from infected
eels (Callol et al., 2015a); (iii) regulatory CK such as, LTA (or
TNF-β), IL-17 (implicated in triggering and mediating pro-
inflammatory response, by inducing the expression of different
pro-inflammatory CKs, CCs, antimicrobial peptides, growth
factors among others); iv) IFN-related genes (associated with
CD8+ T cells) such as, ifna2, Ifnb1, Ifnar1, and Ifngr1; (v) CKs
involved in the regulation and stimulation of haematopoiesis
such as, IL-3, IL-4, IL-7 and CSF2 (this activation could lead
to a rapid innate immune system replenishment, exacerbating
the inflammatory response); (vi) the inducible NO synthase
gene that mediates tumoricidal and bactericidal actions, mainly
intracellular (Maeda and Akaike, 1998); and (vii) members of
the inflammasome complex such as, NLRC4, PYCARD, and
Caspase-1, that have been previously involved in macrophage
death by pyroptosis induced by the facultative intracellular
pathogen Legionella pneumophila (Case and Roy, 2011; Cerqueira
et al., 2015). We also found evidence of a dysregulation of
CK production. Thus, DUSP1 (MKP-1) was activated by both
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FIGURE 7 | Heat Map. Heat map representing color-coded expression levels of the 84 genes analyzed in infected mice for 4 h with strains Bt2-SerE R99 and
Bt1-RtxA11 YJ016, and their derivative RtxA1 mutants. Genes are arranged in functional categories.
strains but was significantly more induced by YJ016 (Table 2).
MKP-1 regulates, via dephosphorylation, the activation of several
MAPK including p38, thus limiting their signaling potential and
the production of pro-inflammatory CKs (Zhao et al., 2006;
Wang and Liu, 2007; Moyes et al., 2010). In agreement with the
pattern of DUSP1 activation, the Mapk14 gene (or p38α) was
up-regulated by the Bt2-SerE strain, but down-regulated by the
selected Bt1-RtxA11 strain. In contrast, mice infected with the
Bt1-RtxA11-strain developed a typical immune response against
an extracellular pathogen: most of the CKS genes were down-
regulated in these mice while genes known to have a beneficial
role during extracellular bacterial infections (Il6, Tnf or Lcn2)
were clearly up-regulated (Shin et al., 2002; Berger et al., 2006;
Goo et al., 2007; Chuang et al., 2010). Finally, we also found that
the Bt1-RtxA11 strain induced high levels of the CCs Ccl3 and
Cxcl1. CXCL1 has been recently proven to play a crucial role in
the inflammatory response developed against Bt1 V. vulnificus
infection by reducing hepatic injury (Liu et al., 2015). In contrast,
the Bt2-SerE strain only induced these CC at lower levels at 6 hpi,
which could contribute to the severity of the disease.
By comparing the immune responses against Bt1-RtxA11
and Bt2-SerE strains we can predict that the common response
against any V. vulnificus strain would involve, at least, the
activation of a series of genes related to LPS recognition (Tlr4
and Cd14) (Kawai and Akira, 2009) together with several genes
for the IL-1 family (Il1a, Il1b, Il1r2), IL-6, and Pf4 as well as
Tfrc. Previous works performed with Bt1 strains had already
highlighted the important role of TLR4, IL-1α, IL-1β, IL-6,
CXCL1, or CCL3 in the response against V. vulnificus (Shin et al.,
2002; Chuang et al., 2010; Stamm, 2010; Mayer et al., 2014; Liu
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FIGURE 8 | Principal Component Analysis (PCA) 3-D plot of the gene
expression. Three principal components are represented, PC1 on X-axis, PC2
on Y-axis, and PC3 on Z-axis. (A) shows the analysis of mice infected for 4 h
with the wild-type strains and their derivative RtxA1 mutants. In (B) mice
infected with the Bt2-SerE R99 strain for 2 and 6 h were included in the
analysis.
et al., 2015). However, none of them had reported the activation
of either Tfrc, a gene encoding a cell surface receptor necessary
for transferrin recycling and iron uptake, or Pf4. Transferrin is
one of the acute-phase proteins that are produced by the liver
in response to extracellular bacterial infections, which in turn
produce iron-sequestering and a nutritional immunity (Parrow
et al., 2013). The activation of Tfrc by blood cells would be an
indirect signal that transferrin is being produced by the liver.
Pf4, which was by far the most up-regulated gene by the Bt1
strain, is released by activated platelets, binds to the bacterial
surface inducing the formation of neoepitopes, and facilitates
bacterial clearance (Krauel et al., 2011). Specifically, PF4 binds
FIGURE 9 | rtxA1 expression in the presence of human blood cells. (A)
Expression by Real time qPCR of rtxA11 and rtxA13 in YJ016 and R99 strains,
respectively. Bacteria were incubated for 0, 2, 4, and 6 h in commercial human
serum supplemented with Fe (Hm-serum) plus human PBMCs. The value of
expression of each gene in the 0 h sample was set equal to 1, and the
fold-change in gene expression was calculated in 2, 4, and 6 h samples. (B)
Bacterial growth in commercial human serum with (Hm-serum) or without
supplemented Fe. (A, B) Data represent mean values ± standard deviation
from two independent experiments. The significance of the differences was
determined using Student’s two-tailed t-test; *p < 0.05 compared with values
at time 0 h.
to negatively charged LPS on gram-negative bacteria (Krauel
et al., 2012). Our results further support the hypothesis that
neoepitope formation by PF4 after binding to bacteria is an
ancient and early host defense mechanism against extracellular
pathogens (Krauel et al., 2012). Nevertheless, both tested V.
vulnificus strains are encapsulated (Valiente et al., 2008a) and
capsule would be expected to interfere with PF4 deposition on
LPS, partially explaining why capsulated V. vulnificus strains are
significantly more virulent than acapsulated ones (Simpson et al.,
1987; Strom and Paranjpye, 2000).
Further, we analyzed the immune response pattern by PCA
analysis and found that Bt1-RtxA11 and Bt2-SerE MARTX
mutants grouped together and close to the Bt1-RtxA11 strain.
This proximity in immune response was highlighted even more
when the data from R99-infected mice at 2 and 6 hpi were
introduced in the analysis; three clusters were observed, one
formed by both mutants and the Bt1-RtxA11 strain, another by
the samples taken at 2 and 4 hpi from Bt2-SerE–infected mice,
and the third with an intermediate position formed from the
sample taken at 6 hpi. This finding also suggested that the CKS
induced by Bt2-SerE presents a peak very early, at 4 hpi and
decreasing at 6 h, a model that is compatible with data of the
death dynamic of mice after i.p. infection with Bt2-SerE; most
mice either die before 8 hpi or survive the infection.
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We had previously demonstrated that V. vulnificus Bt2-SerE
induced death by lysis of endothelial cells and by apoptosis of
human monocytes (Murciano et al., 2015). In our present work,
we linked both activities with RtxA13, which suggests that this
toxin can induce cell death by different mechanisms depending
on the target cell. RtxA13 differs from the otherMARTXVv in that
possesses a copy of an ACD domain, in common with MARTX
of V. cholerae, and two copies of the MCF domain, a domain also
present in other MARTXVv but in only one copy (Lee et al., 2007;
Liu et al., 2007; Kim et al., 2008, 2015; Kwak et al., 2011; Lo et al.,
2011; Roig et al., 2011; Jeong and Satchell, 2012; Satchell, 2015).
Moreover, all the Bt2-SerE strains possess two identical copies
of rtxA13, one in chromosome II and another in the virulence
plasmid pVvBt2 (Roig et al., 2011). Thus, we tested if the ACD
domain in RtxA13 was also capable of polymerizing actin and
found that this domain effectively caused a strong and rapid actin
oligomerization in vitro in both cell types. However, the ACD
domain was not revealed as essential for apoptosis of monocytes
in vitro, suggesting that the apoptotic activity on monocytes
probably was caused by MCF domains present as four copies per
bacterium. In partial accordance, it was previously described that
MCF domains on other MARTXVv induce the intrinsic pathway
of apoptosis (Agarwal et al., 2015b).
Looking in depth the immune-pattern specific for RtxA13 and
the mode of action of this toxin, we conclude that, whatever the
attacked cell is, either the toxin facilitates bacterial invasion or,
alternatively, the toxin by itself activates an immune response
that, at least to some extent, is similar to that produced against
intracellular pathogens like L. pneumophila. Regarding the first
possibility, we have never seen bacteria inside eukaryotic cells
either in the experiments performed in previous works or in these
experiments.We tested the second possibility in vitro by infecting
the two human cell lines with R99 and its mutant and analyzing
the expression of selected CK and CC genes. Regrettably, cells
infected with the wild-type strain died early, which resulted in an
apparently stronger immune response against the mutant (results
not shown), and suggesting that this in vitro approach was not
adequate to test the hypothesis. In any case and whatever the
CKS-activation mechanism is, the fact that this toxin is linked
to this storm is exciting, as RtxA13 could be representative of a
new family of toxins able to trigger a life threatening immune-
response. Figure 10 summarizes a hypothetical model for sepsis
induced by RtxA13 in which we propose that not only blood
cells but also endothelial cells would be involved. Previously
we had demonstrated that endothelial cells can produce, in
vitro, multiple inflammatory mediators when they are infected
with V. vulnificus Bt2-SerE (Murciano et al., 2015) This would
enhance the destructive effect on mediators liberated by blood
cells. Finally, we discarded the possibility that this early CKS was
due to bacterial growth in blood; bacteria were present in internal
organs of infected mice below the detection limit (<10 CFU/mL)
since they could be only recovered after enrichment.
Our next step was to find out if rtxA1 would be expressed
in humans by using an ex vivo model of infection. We found
that both rtxA13 and rtxA11 were highly expressed at 2 hpi in
human blood, confirming the results obtained in the mouse. We
completed these experiments by growing the bacteria in normal
and hm-serum. Interestingly, the Bt2-SerE strain was only able
to grow in hm-serum while YJ016 grew in both normal and
hm-serum. It is generally assumed that V. vulnificus is only able
to cause death by sepsis in patients with high iron-levels in
blood, although there are a few clinical cases of sepsis in healthy
patients described in the literature. YJ016 was selected for the
study because it is representative of the phylogenetic lineage that
groups the most virulent Bt1 strains, most of them linked to
primary septicaemia after raw seafood ingestion (Cohen et al.,
2007; Sanjuán et al., 2011). According to our results, YJ016 would
also be representative of the group of V. vulnificus strains able to
cause sepsis in healthy patients.
Epidemiological data reveal that the number of cases of sepsis
caused by Bt1 strains is by far much higher than those caused
by Bt2-SerE, which never has been linked to primary sepsis
after oyster ingestion. These data could lead us to underestimate
the public health danger that represents this zoonotic group.
In fact, a clinical Bt1 strain has been shown to carry an RtxA1
toxin with the same domain organization as the Bt2-SerE strain,
although that strain only had the chromosomal copy of the
toxin as it did not have any plasmids (Kwak et al., 2011). This
further demonstrates the risk potential of RtxA13 for humans.
At the moment, it seems that its geographical distribution is
more restricted (Amaro et al., 2015), and its apparent inability
to colonize oysters (Amaro et al., 2015) prevents it from being
associated with a higher number of clinical cases.
V. vulnificus Bt2 shows an extraordinary ability to adapt to the
environment, i.e., after substituting saline water by freshwater in
eel-farms to control vibriosis, a new Bt2-serovar, able to survive
and infect in freshwater, emerged in <5 years (Fouz et al., 2006).
Climate change is increasing water temperature and decreasing
water salinity, which could extend the geographical distribution
of Bt2-SerE and increase the probability of contact with its
intermediate reservoir, oysters, and with its end host, humans.
This fact together with the fast adaptation of this Bt to external
changes suggests a complicated picture for the next years.
In conclusion, for the first time, and by using a murine model
of infection, we have demonstrated that the sepsis from vibrosis
caused by the Bt2-SerE of V. vulnificus could occur through
the type III MARTXVv toxin, which induces an erroneous and
dysregulated immune response that would lead to a rapid CKS
and, in the end, to death of its host. The specific pattern
of the immune response associated to this CKS revealed that
the pathogen has either an unknown intra-cellular life stage
or, which seems more probable, that the toxin triggers a life-
threatening immune response after attacking different immune
cells. Although the precise molecular mechanism for the toxic
action remains to be determined, we predict that the toxigenic
potential of RtxA13 is probably not due to the effect of a single
domain (ACD vs. MCF) but to the unique combination of
domains (ACD + 2MCF) along with duplication of the gene
in the bacterium. This statement is based on previous results
obtained with a different mouse strain in which we found that
deletion of only one copy of the rtxA13 gene, either the plasmidic
or the chromosomic one, only reduced virulence by 1-log (Lee
et al., 2013), and on the results shown here, the expression level
of rtxA13 in human blood being four times the expression level
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FIGURE 10 | Schematic model of V. vulnificus Bt2-SerE induced sepsis. V. vulnificus Bt2-SerE would cause sepsis only in patients with high iron levels in blood, and
according to the following model: (1) the bacterial cells would reach the endothelial microvasculature from the infection site. There, they will infect the endothelial cells,
producing RtxA13 that would enter the host cell and cause death by lysis, allowing the bacterium to invade the blood stream (2). (3) There, the bacterial cells, in low
number, would interact with different types of immune blood cells. Once in contact, the bacteria would produce and again liberate RtxA13 into the host cell cytoplasm
(see detail in the lower part of the figure). This toxin, together with a superficial recognition of bacterial cells by extracellular and intracellular receptors, would induce
activation of different signaling pathways and transcription factors that in turn would produce the activation of apoptosis and/or inflammasome and the secretion of
CKs, CCs, and other immune mediators. Although, intracellular receptors are activated, it is not clear if the bacterium is able to enter into the cell cytoplasm or if this
activation is triggered by RtxA13 domains or other bacterial components. Thus, the hypothetic intra-cellular life style of V. vulnificus Bt2-SerE and/or the mechanism
for this anomalous immune response activation remains to be investigated. (4) The inflammatory proteins in response to the infection would recruit and activate
additional immune cells. These new cells, which could also be infected with bacteria, would be activated to such a great extent that they will suffer gene dysregulation
and a CSK would start, which in turn would produce the host’s death by sepsis (5).
of rtxA11. Finally, even though the clinical signs of sepsis caused
by Bt1-RtxA11 and Bt2-SerE could converge, the mechanisms by
which death occurs would be different. Bt2-SerE would induce
a dysregulated immune response and a septic shock in which
RtxA13 would be critical, while the sepsis caused by Bt1-RtxA11
would be similar to that induced by other gram-negative bacteria,
being linked to growth in blood and LPS liberation (Opal, 2010;
Ramachandran, 2014).
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